Back to Results
First PageMeta Content
GlaxoSmithKline / Glucocorticoids / Organofluorides / Fluticasone/salmeterol / Salmeterol / Fluticasone propionate / Asthma / Dry powder inhaler / Spirometry / Pulmonology / Medicine / Respiratory therapy


Public Assessment Report for paediatric studies submitted in accordance with Article 46 of Regulation (EC) No1901/2006, as amended Seretide
Add to Reading List

Document Date: 2013-06-20 11:23:14

Open Document

File Size: 123,14 KB

Share Result on Facebook

Company

GlaxoSmithKline / AEs / Pharmacotherapeutic Group / Double-Blind / R03AK06 Pharmaceutical / ITT / /

Country

United Kingdom / /

Event

FDA Phase / /

Facility

Seretide Diskus/Viani Diskus INN / /

IndustryTerm

propionate combination product / pharmaceutical formulation / combination product / medicinal products / /

MedicalCondition

Asthma Salmeterol/Fluticasone / Oral candidiasis / symptomatic asthma / pneumonia / headache / persistent asthma / cough / severe asthma / asthma / /

Movie

Male and female / /

Organization

European Union / /

Position

investigator / CONTENTS I. Executive / controller / EXECUTIVE / /

Product

fluticasone propionate / Latte W10 Portable Audio Device / albuterol / beta-2 / FSC / EU / /

ProgrammingLanguage

FP / /

SocialTag